Back
NAPCO Security Technologies Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
51
NSSC
NAPCO Security Technologies
Last Price:
38.63
Seasonality Move:
9.89%
Sell
25
ASND
Ascendis Pharma AS
Last Price:
124.12
Seasonality Move:
11.25%
Buy
51
NAPCO Security Technologies (NSSC)
is a Buy
Is NAPCO Security Technologies a Buy, Sell or Hold?
- The current NAPCO Security Technologies [NSSC] share price is $38.59. The Score for NSSC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- NSSC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $124.33. The Score for ASND is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NSSC Stock Price Chart
What is NAPCO Security Technologies's stock price today?
-
The NAPCO Security Technologies share price today is $38.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSSC is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $124.33
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
NSSC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.88 | Sell |
| Relative Strength Index (14 RSI): | 47.41 | Sell |
| Chaikin Money Flow: | -6502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.49 - 40.75) | Sell |
| Bollinger Bands (100): | (39.02 - 53.76) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.39 | Sell |
| Relative Strength Index (14 RSI): | 40.9 | Sell |
| Chaikin Money Flow: | -343585 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.76 - 133.22) | Sell |
| Bollinger Bands (100): | (125.03 - 141.83) | Sell |
NSSC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.67 | Buy |
| 20-day SMA: | 39.2 | Sell |
| 50-day SMA: | 39.43 | Sell |
| 200-day SMA: | 44.87 | Sell |
| 8-day EMA: | 37.97 | Buy |
| 20-day EMA: | 38.7 | Sell |
| 50-day EMA: | 40.9 | Sell |
| 200-day EMA: | 42.53 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.61 | Sell |
| 20-day SMA: | 127.56 | Sell |
| 50-day SMA: | 132.48 | Sell |
| 200-day SMA: | 137.31 | Sell |
| 8-day EMA: | 126.45 | Sell |
| 20-day EMA: | 128.47 | Sell |
| 50-day EMA: | 131.53 | Sell |
| 200-day EMA: | 130.72 | Sell |
NAPCO Security Technologies Earnings Growth & NSSC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.06 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.
NAPCO Security Technologies Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||